Coya Therapeutics Announces Publication of Potential Novel Blood Biomarker Data in Amyotrophic Lateral Sclerosis (ALS) Patients That Accurately Reflect Therapeutic Responses When Treated with Regulatory T Cell (Treg) Enhancing Therapies - Allele Capital

https://ir.coyatherapeutics.com/news/news-details/2023/Coya-Therapeutics-Announces-Publication-of-Potential-Novel-Blood-Biomarker-Data-in-Amyotrophic-Lateral-Sclerosis-ALS-Patients-That-Accurately-Reflect-Therapeutic-Responses-When-Treated-with-Regulatory-T-Cell-Treg-Enhancing-Therapies/default.aspx